These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9828216

  • 21. Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats.
    Veal N, Oberti F, Moal F, Vuillemin E, Fort J, Kaassis M, Pilette C, Calès P.
    J Hepatol; 2000 Mar; 32(3):434-40. PubMed ID: 10735613
    [Abstract] [Full Text] [Related]

  • 22. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
    Yang YY, Huang YT, Lee KC, Lee FY, Lee TY, Hou MC, Lin HC, Lee SD.
    Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
    [Abstract] [Full Text] [Related]

  • 23. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
    Mayoral P, Criado M, Hidalgo F, Flores O, Arévalo MA, Eleno N, Sánchez-Rodríguez A, López-Novoa JM, Esteller A.
    Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
    Van de Casteele M, Roskams T, Van der Elst I, van Pelt JF, Fevery J, Nevens F.
    Liver Int; 2004 Oct; 24(5):502-9. PubMed ID: 15482349
    [Abstract] [Full Text] [Related]

  • 26. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
    Yao HW, Li J, Chen JQ, Xu SY.
    Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
    [Abstract] [Full Text] [Related]

  • 27. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.
    Moal F, Veal N, Vuillemin E, Barrière E, Wang J, Fizanne L, Oberti F, Douay O, Gallois Y, Bonnefont-Rousselot D, Rousselet MC, Calès P.
    World J Gastroenterol; 2006 Nov 07; 12(41):6639-45. PubMed ID: 17075977
    [Abstract] [Full Text] [Related]

  • 28. Effect of splenectomy on CCl4-induced liver fibrosis in rats.
    Chen D, Liu W, Leng E, Wu B.
    Chin Med J (Engl); 1998 Sep 07; 111(9):779-83. PubMed ID: 11155665
    [Abstract] [Full Text] [Related]

  • 29. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2006 Jan 07; (520):4-246. PubMed ID: 16628245
    [Abstract] [Full Text] [Related]

  • 30. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G, Mohammadi-Karakani A, Sotoudeh M, Ghazi-Khansari M, Ghobadi G, Shakiba B.
    Biomed Pharmacother; 2008 Jun 07; 62(5):312-6. PubMed ID: 18191530
    [Abstract] [Full Text] [Related]

  • 31. Haemodynamic and renal evolution of the bile duct-ligated rat.
    Martínez-Prieto C, Ortíz MC, Fortepiani LA, Ruiz-Maciá J, Atucha NM, García-Estañ J.
    Clin Sci (Lond); 2000 May 07; 98(5):611-7. PubMed ID: 10781394
    [Abstract] [Full Text] [Related]

  • 32. Emodin on hepatic fibrosis in rats.
    Zhan Y, Li D, Wei H, Wang Z, Huang X, Xu Q, Lu H.
    Chin Med J (Engl); 2000 Jul 07; 113(7):599-601. PubMed ID: 11776026
    [Abstract] [Full Text] [Related]

  • 33. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
    Croquet V, Moal F, Veal N, Wang J, Oberti F, Roux J, Vuillemin E, Gallois Y, Douay O, Chappard D, Calès P.
    J Hepatol; 2002 Dec 07; 37(6):773-80. PubMed ID: 12445418
    [Abstract] [Full Text] [Related]

  • 34. Prevention of liver cirrhosis in rats by curcumin.
    Bruck R, Ashkenazi M, Weiss S, Goldiner I, Shapiro H, Aeed H, Genina O, Helpern Z, Pines M.
    Liver Int; 2007 Apr 07; 27(3):373-83. PubMed ID: 17355460
    [Abstract] [Full Text] [Related]

  • 35. The effect of terlipressin on hepatic hemodynamics in small-for-size livers.
    Ren Z, Xu Y, Zhu S.
    Hepatogastroenterology; 2012 Apr 07; 59(113):208-11. PubMed ID: 21940362
    [Abstract] [Full Text] [Related]

  • 36. Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats.
    Kemp W, Kompa A, Phrommintikul A, Herath C, Zhiyuan J, Angus P, McLean C, Roberts S, Krum H.
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct 07; 297(4):G762-7. PubMed ID: 19797237
    [Abstract] [Full Text] [Related]

  • 37. [Effect of Fuzheng Jiangan formula on liver fibrosis induced by albumin in rats].
    Huang XA, Sun LH, Song CS, Cui N, Chen YL, Xu HY, Ren Y.
    Zhongguo Zhong Yao Za Zhi; 2006 Nov 07; 31(22):1890-3. PubMed ID: 17285992
    [Abstract] [Full Text] [Related]

  • 38. Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction.
    Tracy TF, Tector AJ, Goerke ME, Kitchen S, Lagunoff D.
    Am J Pathol; 1993 Dec 07; 143(6):1574-8. PubMed ID: 8256850
    [Abstract] [Full Text] [Related]

  • 39. Hemodynamic effects of Salvia miltiorrhiza on cirrhotic rats.
    Huang YT, Lee TY, Lin HC, Chou TY, Yang YY, Hong CY.
    Can J Physiol Pharmacol; 2001 Jul 07; 79(7):566-72. PubMed ID: 11478589
    [Abstract] [Full Text] [Related]

  • 40. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats.
    Işeri SO, Sener G, Saglam B, Ercan F, Gedik N, Yeğen BC.
    Regul Pept; 2008 Feb 07; 146(1-3):73-9. PubMed ID: 17884193
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.